James M. Bennett
Papers
4
Total Citations
18
H-Index
3
About
James M. Bennett has established himself as a pioneering figure in fragment-based drug discovery, with a particular focus on developing innovative methodologies to overcome one of the field's most persistent bottlenecks: efficiently progressing weakly binding fragment hits into potent drug candidates. His most impactful contribution is the development of Binding-Site Purification of Actives (B-SPA), a groundbreaking approach that integrates multi-step array synthesis with high-throughput (HT) crystallography to dramatically accelerate the fragment-to-lead optimization process. This methodology, refined across multiple landmark publications between 2023 and 2025, leverages low-cost robotics and sophisticated analytic deconvolution techniques to extract rich structural data from crude reaction mixtures, democratizing access to crystallographic workflows that were previously resource-intensive and slow. His work has collectively garnered nearly 20 citations in just a few years, reflecting rapid uptake within the structural biology and medicinal chemistry communities. Beyond his primary research domain, Bennett has also explored the intersection of artificial intelligence and diagnostic medicine, examining lessons from COVID-19 on AI-powered early disease detection. His diverse contributions position him as a versatile innovator bridging computational innovation, structural biology, and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4